secwatch.observer — SEC 8-K summary
======================================

Issuer:     PFIZER INC (PFE)
CIK:        0000078003
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0000078003-24-000130
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pfizer begins external search for successor to Chief Scientific Officer Mikael Dolsten
--------------------------------------------------------------------------------

- CSO and President of R&D Mikael Dolsten to step down after over 15 years; external search launched.
- Dr. Dolsten will stay in current role until successor is appointed, at least through Feb 28, 2025.
- No successor named; transition process formally announced on July 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/0000078003-24-000130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/pfe-20240709.htm
  HTML page:      https://secwatch.observer/filing/0000078003-24-000130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer